Disc Medicine (IRON) is back in focus after the FDA issued a Complete Response Letter for its lead EPP drug, bitopertin, asking for additional Phase 3 data and delaying the potential approval timeline ...

Disc Medicine Inc. IRON shares closed around 22% lower on Friday as the company navigates a regulatory hiccup with a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) ...

It took more than three quarters, but the first touchdown of Super Bowl 60 came via a 16-yard pass, and it was Seattle Seahawks tight end AJ Barner who had the honor of punching it in for the score.

Pursuing a traditional approval path for bitopertin in erythropoietic protoporphyria (EPP); Phase 3 APOLLO study is expected to complete enrollment in March 2026 with topline data expected in Q4 2026I ...

The report also underscores an odd aspect of the U.S. economy: It is growing steadily, but without creating many jobs. Growth was a fairly healthy 2.2% in 2025, yet a government report last week ...

The US economy grew at a much slower pace in the final months of 2025 as the historic government shutdown weighed on economic activity, ending a year that saw the weakest growth since the pandemic.

Disc Medicine develops therapies for rare blood disorders, leveraging clinical-stage biotech expertise in red blood cell biology.

MANILA, Philippines — The government plans to spend P1.4 billion in the first quarter of 2026 to support economic recovery, Department of Finance (DOF) Secretary Frederick Go said on Friday. “It’s ...

Reddit reported fourth-quarter earnings on Thursday in which the social media company beat on the top and bottom lines.

A four-star safety from California has settled on his top five, leaving the Aggies to compete with some elite West Coast programs.